Femasys (FEMY) announces the Company has secured strategic distribution partnerships for FemBloc in Spain. Comercial Medico Quirurigca, SA will expand its commercial portfolio to include FemBloc, alongside other Femasys products in northern Spain, while Durgalab will handle distribution in the southern region.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FEMY:
- Femasys Achieves CE Mark for FemBloc, Paving the Way for European Market Entry and Justifying Buy Rating
- Femasys announces FemBloc delivery system approval in Europe
- Femasys’s FemBloc: A Promising Investment in Permanent Contraceptive Innovation
- Femasys announces publication of ‘positive’ results from FemBloc trials
- Femasys announces UK regulatory approvals for FemaSeed